BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 164 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $959,000 | +4.2% | 8,950 | -0.0% | 0.02% | +4.2% |
| Q3 2021 | $920,000 | +31.6% | 8,951 | +12.6% | 0.02% | +14.3% |
| Q2 2021 | $699,000 | +421.6% | 7,950 | +448.3% | 0.02% | +250.0% |
| Q3 2020 | $134,000 | -79.4% | 1,450 | -82.1% | 0.01% | -76.0% |
| Q4 2019 | $649,000 | +1375.0% | 8,100 | +1250.0% | 0.02% | +1150.0% |
| Q3 2019 | $44,000 | -93.9% | 600 | -93.5% | 0.00% | -95.2% |
| Q3 2018 | $716,000 | +215.4% | 9,172 | +156.3% | 0.04% | +200.0% |
| Q2 2018 | $227,000 | +404.4% | 3,579 | +496.5% | 0.01% | +250.0% |
| Q4 2017 | $45,000 | +275.0% | 600 | +155.3% | 0.00% | +300.0% |
| Q2 2017 | $12,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |